Mati Therapeutics Inc. — Form D

Mati Therapeutics Inc. of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-24. The offering totals $1.5M, of which $165K was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Robert Lee Butchofsky IIDirectorAustin, TX
Christopher Lee MullerDirectorFoothill Ranch, CA
Deepank Lee UtkhedeDirectorSurrey, A1
Robert Lee Butchofsky IIExecutive OfficerAustin, TX
Christopher Lee MullerExecutive OfficerFoothill Ranch, CA
Cameron Lee NelsonExecutive OfficerVancouver, A1
Deepank Lee UtkhedeExecutive OfficerSurrey, A1
Deepank UtkhedeDirectorAustin, TX
Robert ButchofskyDirectorAustin, TX
Robert ButchofskyExecutive OfficerAustin, TX
Robert ButchofskyRelated PersonAustin, TX
Christopher MullerDirectorAustin, TX
Christopher MullerExecutive OfficerAustin, TX
Christopher MullerRelated PersonAustin, TX
Cameron NelsonExecutive OfficerAustin, TX
Cameron NelsonRelated PersonAustin, TX
Joseph Tortorice IIIDirectorAustin, TX
Joseph Tortorice IIIRelated PersonAustin, TX
Ken JonesRelated PersonAustin, TX
Peter McDonnellRelated PersonAustin, TX
Jim MazzoRelated PersonAustin, TX
Deepank Lee UtkedeDirectorAustin, TX
Deepank Lee UtkedeExecutive OfficerAustin, TX
Chris Lee MullerDirectorAustin, TX
Chris Lee MullerExecutive OfficerAustin, TX

Other filings by this issuer (6)

FiledFormOfferingSold
2026-07-02D/A$4.9M$2.6M
2025-10-08D$10.5M$9.9M
2025-09-23D$2.2M$2.2M
2018-10-16D$1.2M$50K
2014-10-10D$13.8M$150K
2013-04-15D$10.0M$1.3M

More